Delivery Order SPE2DB20D3101-SPE2DB23FRYF0

Award Date 9/19/23
Potential Completion Date 9/20/23
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Humalog 100 unit/mL vial, 10mL (product code 4565937366) to the Defense Logistics Agency (DLA). The $1,639.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 25, 2024 with a completion date of September 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Humalog 100 unit/mL vial 10mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,257.20 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 26, 2022. The contract does not have a set-aside designation, indicating an open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,530.86 firm fixed-price delivery order is for the supply of Humalog 100 Unit/ML vials, a medication used to treat diabetes. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/ml vial 10ml. The contract has a ceiling value of $1,381.72 and was awarded on August 11, 2021, with an ultimate completion date of August 12, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract. The $5,464.80 award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 12, 2024, with a completion date of June 13, 2024. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/mL vial 10mL. The $3,528.80 firm fixed-price delivery order contract has an ultimate completion date of October 15, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,518.40 firm fixed-price contract is for the delivery of Humalog 100 Unit/mL vials with a 10mL volume. The award was made on May 30, 2023, with a completion date of May 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 9, 2022, with a ceiling value of $2,277.00 and a completion date of November 10, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This federal contract award is for the delivery of Humalog 100 unit/mL vial 10mL, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,764.40 and a completion date of September 19, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,828.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humalog 100 unit/ml vial 10ml. The contract has an ultimate completion date of October 18, 2022 and is a firm fixed-price delivery order. This contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYF0
    Delivery Order

This federal contract award is for the delivery of Humalog 100 unit/mL vial 10mL, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,830.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 19, 2023, with a completion date of September 20, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a key supplier to the DoD and VA healthcare systems, Amerisourcebergen leverages its expertise in pharmaceutical distribution to efficiently fulfill government contracts for essential medical commodities.

Generated 2/27/25, 10:36 AM